The surfactant assisted polymerization of 1-vinyl-2-pyrrolidone in supercritical carbon dioxide in the presence of Piroxicam, selected as a model of a low aqueous solubility drug, was studied in order to prepare in a single step a polymeric composite to enhance the rate of dissolution of the pharmaceutical compound. Reactive entrappingwas carried out at 65 ◦C in theP range 21–38MPa.Under proper operative conditions we obtained the composite under the form of sub-micron spherical particles with relatively narrowparticle size distribution. Drug loadings higher than 12% (w/w)were obtained andXRDand Raman spectroscopy suggest that the anti-inflammatory agent is dispersed in the matrix with a non-crystalline structure. The dissolution rate of the drug from the composites was significantly faster both than that of the pure compound and of its physical mixture with the polymer. Collected results suggest that the proposed one-pot process can be used to prepare polymer based composites to increase bioavailability of low solubility drugs without utilization of toxic solvents and under mild temperature conditions.
Galia, A., Scialdone, O., Filardo, G., Spanò, T. (2009). A one-pot method to enhance dissolution rate of low solubility drug molecules using dispersion polymerization in supercritical carbon dioxide. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 377, 60-69 [10.1016/j.ijpharm.2009.05.001].
A one-pot method to enhance dissolution rate of low solubility drug molecules using dispersion polymerization in supercritical carbon dioxide
GALIA, Alessandro;SCIALDONE, Onofrio;FILARDO, Giuseppe;SPANO', Tiziana
2009-01-01
Abstract
The surfactant assisted polymerization of 1-vinyl-2-pyrrolidone in supercritical carbon dioxide in the presence of Piroxicam, selected as a model of a low aqueous solubility drug, was studied in order to prepare in a single step a polymeric composite to enhance the rate of dissolution of the pharmaceutical compound. Reactive entrappingwas carried out at 65 ◦C in theP range 21–38MPa.Under proper operative conditions we obtained the composite under the form of sub-micron spherical particles with relatively narrowparticle size distribution. Drug loadings higher than 12% (w/w)were obtained andXRDand Raman spectroscopy suggest that the anti-inflammatory agent is dispersed in the matrix with a non-crystalline structure. The dissolution rate of the drug from the composites was significantly faster both than that of the pure compound and of its physical mixture with the polymer. Collected results suggest that the proposed one-pot process can be used to prepare polymer based composites to increase bioavailability of low solubility drugs without utilization of toxic solvents and under mild temperature conditions.File | Dimensione | Formato | |
---|---|---|---|
IntJPharm_2009_Piroxicam.pdf
Solo gestori archvio
Dimensione
1.3 MB
Formato
Adobe PDF
|
1.3 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.